NanoVibronix, Inc. (NAOV) News
Filter NAOV News Items
NAOV News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NAOV News Highlights
- For NAOV, its 30 day story count is now at 2.
- Over the past 2 days, the trend for NAOV's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about NAOV are WAVE.
Latest NAOV News From Around the Web
Below are the latest news stories about NANOVIBRONIX INC that investors may wish to consider to help them evaluate NAOV as an investment opportunity.
NanoVibronix Featured in Your Bladder Health MagazineELMSFORD, N.Y., December 06, 2023--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that its UroShield is featured in Issue 103 of Your Bladder Health Magazine in an article titled ‘UroShield Prevention is better than cure.’ The article highlights the effectiveness of using UroShield in the prevention of catheter associated urinary tract infe |
NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution OpportunityELMSFORD, N.Y., December 04, 2023--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into a non-binding letter of intent (the "LOI") with APOGEPHA Arzneimittel GmbH ("APOGEPHA") in which both parties will analyze the potential for APOGEPHA to distribute NanoVibronix’s premiere UroShield product in Germany and other European |
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of MichiganELMSFORD, N.Y., November 28, 2023--NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has signed a Research Agreement with the Regents of the University of Michigan for a Randomized Control Trial ("RCT") study of UroShield. |
NanoVibronix Regains Nasdaq ComplianceELMSFORD, N.Y., November 21, 2023--NanoVibronix, Inc., (NASDAQ: NAOV) (the "Company"), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that on November 20, 2023, the Company received official notice from The Nasdaq Stock Market LLC that the Company has evidenced compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the minimum stockholders’ eq |
NanoVibronix Issues Letter to ShareholdersELMSFORD, N.Y., November 14, 2023--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today issued a letter to shareholders from its Chief Executive Officer, Brian Murphy, providing a review of the third quarter 2023 and recent business developments. |
NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1ELMSFORD, N.Y., November 07, 2023--NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that effective November 1, its UroShield actuators are eligible for reimbursement on NHS Prescription Services’ Drug Tariff. |
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug TariffELMSFORD, N.Y., September 27, 2023--NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that its application for UroShield actuators to be available on NHS Prescription Services’ Drug Tariff has been approved. |
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual MeetingELMSFORD, N.Y., September 06, 2023--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that Dr. Sandra Wilks is scheduled to present the findings from her study of UroShield® at the International Continence Society (ICS) 2023 Conference in Toronto on Wednesday, September 27. |
Dear ACHR Stock Fans, Mark Your Calendars for Sept. 12Archer Aviation (ACHR) stock fans will want to keep an eye on the urban air mobility company when Sept. 12, 2023, rolls around! |
Why Is NanoVibronix (NAOV) Up 153% Today?NanoVibronix (NAOV) stock is climbing higher on Wednesday after releasing independent results from a study of its UroShield medical device. |